DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Personnel CompuGroup Medical extends contract with CFO Michael Rauch ahead of schedule by a further five years 2021-11-02 / 14:50 The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

Koblenz. CompuGroup Medical SE & Co. KGaA (CGM), one of the world's leading e-health providers, informs that the Administrative Board of CompuGroup Medical Management SE today has decided to extend the contract of Chief Financial Officer (CFO) Michael Rauch by a further five years until July 31, 2027.

Diplom-Kaufmann (Univ.) Michael Rauch, MBA, LL.M took over as CFO of CompuGroup Medical SE on August 1, 2019 and was

- amongst other achievements - instrumental in the process to convert the company into CompuGroup Medical SE & Co. KGaA (partnership limited by shares). During his first tenure CGM advanced from SDAX into MDAX in September 2019 and has completed three of the four largest acquisitions in its history.

Frank Gotthardt, Founder and Chairman of the Administrative Board, says: "Michael Rauch plays a key role in our Management Board and has contributed significantly to the success of CompuGroup Medical in recent years. This year CGM will surpass the 1 billion Euro mark in revenues for the first time which reflects more than a 40 percent increase in revenues since 2018. In the name of the Administrative Board I would like to thank Michael for his great dedication and commitment to CGM's success, we are looking forward to continuing our collaboration in the years to come."

Dr. Dirk Wössner, CEO, adds: "I am very happy to continue working closely with Michael and to continue CGM's growth story. Michael is a very versatile CFO and a great leader. Besides safeguarding the financial strength of CGM and having a transparent and close dialogue with our investors, he also skillfully balances strategic direction with a sharp eye on the details of company performance and results. Michael is an ideal sparring partner for me and the entire leadership team."

Michael Rauch, CFO, emphasizes: "I would like to thank Frank Gotthardt, Dirk Wössner und the Administrative Board for their continued trust. My clear priority remains long term growth at a high profitability and with a dedicated focus on cashflow, realizing the benefits of further digitization in healthcare and also in future generating additional value for our customers, employees and shareholders." About CompuGroup Medical SE & Co. KGaA CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 837 million in 2020, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists, and other healthcare professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. Approximately 8,500 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system. Contact for media representatives: Michael Franz Head of Brand Communication P +49 261 8000-6100 F +49 261 8000-3100 E-mail: press@cgm.com Contact for analysts and investors: Claudia Thomé Corporate Vice President Investor Relations P +49 261 8000-7030 F +49 261 8000-3200 E-mail: claudia.thome@cgm.com

-----------------------------------------------------------------------------------------------------------------------

2021-11-02 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

----------------------------------------------------------------------------------------------------------------------- 


Language:     English 
Company:      CompuGroup Medical SE & Co. KGaA 
              Maria Trost 21 
              56070 Koblenz 
              Germany 
Phone:        +49 (0)261 8000 7030 
Fax:          +49 (0)261 8000 3200 
E-mail:       investor@cgm.com 
Internet:     www.cgm.com 
ISIN:         DE000A288904 
WKN:          A28890 
Indices:      MDAX, TecDAX 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, 
              Hamburg, Munich, Stuttgart, Tradegate Exchange 
EQS News ID:  1245527 
 
End of News   DGAP News Service 
=------------

1245527 2021-11-02

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1245527&application_name=news

(END) Dow Jones Newswires

November 02, 2021 09:50 ET (13:50 GMT)